Ressler Sigrun, Scheiden René, Dreier Kerstin, Laich Andreas, Müller-Holzner Elisabeth, Pircher Haymo, Morandell Dieter, Stein Ines, Viertler Hans-Peter, Santer Frédéric R, Widschwendter Andreas, Even Jos, Jansen-Dürr Pidder, Capesius Catherine, Zwerschke Werner
Cell Metabolism and Differentiation Research Group, Medical University of Innsbruck, Innsbruck, Austria.
Clin Cancer Res. 2007 Dec 1;13(23):7067-72. doi: 10.1158/1078-0432.CCR-07-1222.
Persistent infections by high-risk human papillomavirus (HPV) types are the main etiologic factor for cervical cancer. The objective of this study was to evaluate whether high-risk E7 oncoprotein is adequate as a marker for the detection of cervical cancer.
HPV typing was done in biopsies from 58 cervical carcinoma and 22 normal cervical squamous epithelia. The HPV-16 E7, HPV-18 E7, and HPV-45 E7 oncoprotein levels were monitored by immunohistochemistry and compared with those of p16(INK4a) and Ki67.
Fifty-five (94.8%) tumors were high-risk HPV-DNA-positive (46 HPV-16, 2 HPV-16 and HPV-18, 4 HPV-18, 1 HPV-33, and 2 HPV-45). HPV-DNA could not be detected in three tumors (5.2%). High HPV E7 oncoprotein levels were shown in 57 cervical cancers (98.3%), without correlation between expression levels and tumor stages.
This is the first study which systematically analyzes the levels of the major HPV oncoproteins in cervical carcinomas demonstrating that the high-risk HPV E7 proteins are regularly expressed in these cancers. This suggests that high-risk E7 oncoproteins are necessary for cervical cancers and apparently essential as tumor marker.
高危型人乳头瘤病毒(HPV)的持续感染是宫颈癌的主要病因。本研究的目的是评估高危型E7癌蛋白是否足以作为检测宫颈癌的标志物。
对58例宫颈癌活检组织和22例正常宫颈鳞状上皮进行HPV分型。通过免疫组织化学监测HPV-16 E7、HPV-18 E7和HPV-45 E7癌蛋白水平,并与p16(INK4a)和Ki67的水平进行比较。
55例(94.8%)肿瘤高危型HPV-DNA阳性(46例HPV-16、2例HPV-16和HPV-18、4例HPV-18、1例HPV-33和2例HPV-45)。3例肿瘤(5.2%)未检测到HPV-DNA。57例宫颈癌(98.3%)显示HPV E7癌蛋白水平较高,表达水平与肿瘤分期之间无相关性。
这是第一项系统分析宫颈癌中主要HPV癌蛋白水平的研究,表明高危型HPV E7蛋白在这些癌症中经常表达。这表明高危型E7癌蛋白是宫颈癌所必需的,显然是必不可少的肿瘤标志物。